Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven H Liang

Showing results (81-90 of 270) with videos related to

Pageof 27
Sort By:
ACS Medicinal Chemistry Letters|May 20, 2026
Novel Substituted Tetrahydropyrrolooxazolones as RIPK1 InhibitorsJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|April 15, 2026
Novel Substituted Indazoles as Small Molecule-Based Inhibitors of KRAS ProteinsJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
Novel Cyclic Peptides as Interleukin-23 Inhibitor for Treating Inflammatory DisordersQi-Long Hu, Steven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Design and Synthesis of Novel USP1 Inhibitors for Therapeutic ApplicationsDanielle E Hoyle, Steven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Novel Bicyclic Peptides Targeting Interleukin-23 Receptor to Relieve Inflammatory ConditionsQi-Long Hu, Steven H Liang
ACS Medicinal Chemistry Letters|June 18, 2025
Deuterated 1,3 Dihydro‑2<i>H</i>‑indole-2-one Derivatives for Treatment of Depression or AnxietyQi-Long Hu, Steven H Liang
ACS Medicinal Chemistry Letters|March 19, 2025
Novel Cyclic Peptides Inhibiting Tumor Necrosis Factor Receptor 1 ActivityQi-Long Hu, Steven H Liang
ACS Medicinal Chemistry Letters|February 19, 2025
Cyclic Peptides Targeting Granzyme B: Potential Applications as PET Imaging AgentsQi-Long Hu, Steven H Liang
ACS Medicinal Chemistry Letters|April 15, 2026
SAR-Guided Scaffold Innovation of Selective V<sub>2</sub>R Antagonists: Therapeutic Frontiers in ADPKDHaofeng Shi, Yinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|March 18, 2026
6,7-Dihalo-Benzothiadiazines as Potent and Selective AMPA Receptor Modulators for Cognitive Enhancement and NeuroprotectionYinlong Li, Hongjie Yuan, Steven H Liang
Pageof 27

Showing results (81-90 of 270) with videos related to

Sort By:
Pageof 27
ACS Medicinal Chemistry Letters|May 20, 2026
Novel Substituted Tetrahydropyrrolooxazolones as RIPK1 InhibitorsJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|April 15, 2026
Novel Substituted Indazoles as Small Molecule-Based Inhibitors of KRAS ProteinsJian Rong, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
Novel Cyclic Peptides as Interleukin-23 Inhibitor for Treating Inflammatory DisordersQi-Long Hu, Steven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Design and Synthesis of Novel USP1 Inhibitors for Therapeutic ApplicationsDanielle E Hoyle, Steven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Novel Bicyclic Peptides Targeting Interleukin-23 Receptor to Relieve Inflammatory ConditionsQi-Long Hu, Steven H Liang
ACS Medicinal Chemistry Letters|June 18, 2025
Deuterated 1,3 Dihydro‑2<i>H</i>‑indole-2-one Derivatives for Treatment of Depression or AnxietyQi-Long Hu, Steven H Liang
ACS Medicinal Chemistry Letters|March 19, 2025
Novel Cyclic Peptides Inhibiting Tumor Necrosis Factor Receptor 1 ActivityQi-Long Hu, Steven H Liang
ACS Medicinal Chemistry Letters|February 19, 2025
Cyclic Peptides Targeting Granzyme B: Potential Applications as PET Imaging AgentsQi-Long Hu, Steven H Liang
ACS Medicinal Chemistry Letters|April 15, 2026
SAR-Guided Scaffold Innovation of Selective V<sub>2</sub>R Antagonists: Therapeutic Frontiers in ADPKDHaofeng Shi, Yinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|March 18, 2026
6,7-Dihalo-Benzothiadiazines as Potent and Selective AMPA Receptor Modulators for Cognitive Enhancement and NeuroprotectionYinlong Li, Hongjie Yuan, Steven H Liang
Pageof 27